gip/glp 1-agonist tirzepatide Frontiers Understand GLP-1/GIP Dual Agonist Tirzepatide

Novel development of a co-formulation of insulin and amylin

[PMCID:PMC11043712]

Diabetes Therapy: 12, 13251339

(2) Advantages Over Synthetics : Natural agonists often exhibit fewer gastrointestinal side effects and additional benefits (e.g., anti-inflammatory, lipid-lowering), though their efficacy and half-life are inferior to drugs like semaglutide

After 8 weeks of follow-up, the administration of lixisenatide increased the phosphorylation of NHE3, which reduced its activity in urinary extracellular vesicles in comparison to once-daily insulin glulisine treatment (Tonneijck et al., 2019)

This provides an anti-diabetic effect by supporting greater insulin sensitivity , which is important because insulin resistance -- caused by our processed foods, toxic environments, and lack of physical activity -- is highly connected with our ongoing societal metabolic syndrome